1. Diagnostic and Translational Research Center, Henry Jackson Foundation, Gaithersburg, MD, USA.
J Cancer. 2011;2:413-24. doi: 10.7150/jca.2.413. Epub 2011 Jul 23.
Carcinogenesis is believed to be a multi-step process, progressing sequentially from normal to hyperplastic, to in situ, and to invasive stages. A number of studies, however, have detected malignancy-associated alterations in normal or hyperplastic tissues. As the molecular profile and clinical features of these tissues have not been defined, the authors invited several well-recognized pathologist, oncologists, biologist, surgeons, and molecular biologist to offer their opinion on: (1) whether these tissues belong to a previously unrevealed malignant entity or focal alterations with no significant consequence? (2) whether these alterations are linked to early onset of cancer or cancer of unknown primary site, and (3) how to further define these lesions?
癌变被认为是一个多步骤的过程,依次从正常、增生、原位到浸润阶段进展。然而,许多研究已经在正常或增生组织中检测到与恶性肿瘤相关的改变。由于这些组织的分子特征和临床特征尚未确定,作者邀请了几位知名的病理学家、肿瘤学家、生物学家、外科医生和分子生物学家就以下问题发表意见:(1) 这些组织是否属于以前未发现的恶性实体或无重要后果的局灶性改变?(2) 这些改变是否与癌症的早期发生或不明原发部位的癌症有关?(3) 如何进一步定义这些病变?